Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › NY › BROOKLYN › FIRST MEDCARE, INC.

FIRST MEDCARE, INC.

NPI: 1578625950 · BROOKLYN, NY 11236 · Multi-Specialty Clinic/Center · NPI assigned 12/14/2006

$12.09M
Total Medicaid Paid
405,980
Total Claims
228,895
Beneficiaries
130
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialKLEIN, GERSHON (PRESIDENT)
NPI Enumeration Date12/14/2006

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 53,155 $2.44M
2019 74,897 $3.30M
2020 42,689 $1.40M
2021 36,303 $932K
2022 127,816 $2.31M
2023 40,272 $928K
2024 30,848 $795K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
D1120 Prophylaxis - child 45,317 11,486 $2.30M
D1330 32,244 8,792 $1.62M
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 20,907 11,703 $1.29M
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 55,137 31,772 $1.02M
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 21,781 7,753 $783K
D1206 Topical application of fluoride varnish 14,606 4,766 $745K
D0150 Comprehensive oral evaluation - new or established patient 10,950 3,736 $550K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 7,559 1,393 $543K
D0120 Periodic oral evaluation - established patient 9,767 6,326 $349K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 1,995 1,853 $224K
D0190 5,262 2,374 $221K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 3,562 3,129 $195K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 30,272 16,504 $193K
D1110 Prophylaxis - adult 5,195 3,943 $176K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 2,219 780 $160K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 1,486 1,418 $154K
99401 4,909 4,151 $151K
D1208 Topical application of fluoride, excluding varnish 3,760 1,750 $117K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 6,668 5,893 $116K
10040 643 490 $97K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years 707 705 $78K
97530 Therapeutic activities, direct patient contact, each 15 minutes 1,030 261 $74K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 819 586 $72K
D0274 Bitewings - four radiographic images 4,210 4,069 $71K
92060 2,681 629 $69K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years 604 603 $69K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 591 582 $63K
17360 711 538 $62K
T1017 Targeted case management, each 15 minutes 2,868 1,329 $59K
99441 357 350 $43K
86328 1,025 984 $38K
92004 Ophthalmological services: medical examination and evaluation, comprehensive, new patient 246 240 $30K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 2,345 2,010 $28K
D0330 Panoramic radiographic image 996 713 $27K
11900 104 90 $23K
97129 258 92 $18K
92551 260 260 $17K
92557 854 477 $17K
11901 76 52 $14K
92014 Ophthalmological services: medical examination and evaluation, comprehensive, established patient 300 181 $12K
D1351 Sealant - per tooth 311 55 $11K
99385 140 140 $11K
11720 431 82 $11K
36415 Collection of venous blood by venipuncture 3,205 3,114 $10K
92201 111 111 $10K
11721 1,429 274 $10K
D0140 Limited oral evaluation - problem focused 737 683 $10K
D0210 Intraoral - complete series of radiographic images 550 546 $9K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination 129 50 $9K
D0220 Intraoral - periapical first radiographic image 976 932 $9K
97116 110 43 $8K
D9920 152 31 $8K
96112 21 12 $7K
97130 89 38 $6K
99173 277 274 $6K
90630 264 264 $6K
99215 Prolong outpt/office vis 52 51 $5K
90682 260 260 $5K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 276 265 $5K
90686 226 226 $4K
D4910 31 26 $4K
90832 Psychotherapy, 30 minutes with patient 41 37 $4K
99442 34 29 $4K
G0442 Annual alcohol misuse screening, 5 to 15 minutes 81 81 $3K
90460 Immunization administration through 18 years of age via any route, first or only component 672 639 $3K
G0444 Annual depression screening, 5 to 15 minutes 87 87 $3K
96160 54 54 $3K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 1,307 1,278 $3K
92020 30 30 $2K
90834 Psychotherapy, 45 minutes with patient 16 12 $2K
99386 40 40 $2K
90715 104 104 $2K
92133 46 46 $2K
76512 277 146 $2K
99050 297 279 $2K
D2392 Resin-based composite - two surfaces, posterior, primary or permanent 43 37 $2K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 12 12 $1K
99490 Ccm add 20min 13 13 $850.57
1111F 9,797 7,900 $832.33
92083 26 26 $803.56
92250 26 26 $803.56
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 12 12 $754.68
99406 17 14 $596.89
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 87 74 $563.58
G0008 Administration of influenza virus vaccine 51 51 $562.06
90649 13 13 $558.94
D4341 34 12 $514.18
93000 1,276 1,259 $509.64
96127 537 486 $454.84
92134 14 12 $393.41
90656 38 38 $363.09
0011A 13 13 $359.94
99497 35 30 $323.50
0012A 20 20 $303.34
92015 Determination of refractive state 18 16 $251.07
92226 201 106 $240.53
81003 1,573 1,552 $215.75
82962 1,271 1,120 $161.01
99051 12 12 $152.28
90633 13 13 $149.93
D0230 Intraoral - periapical each additional radiographic image 16 16 $128.47
90461 36 34 $99.77
90472 Immunization administration, each additional vaccine (list separately) 14 12 $45.87
3078F 6,683 5,608 $41.17
3074F 7,351 6,090 $37.02
81025 40 39 $26.31
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 595 443 $17.69
94760 179 165 $2.70
81002 90 90 $2.00
1159F 10,896 8,697 $2.00
1157F 3,463 3,051 $1.01
G8417 Bmi is documented above normal parameters and a follow-up plan is documented 202 188 $0.15
3077F 2,093 1,831 $0.00
1160F 3,389 2,985 $0.00
0521F 1,150 1,049 $0.00
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 18 18 $0.00
G8431 Screening for depression is documented as being positive and a follow-up plan is documented 201 183 $0.00
99080 38 15 $0.00
99072 29 27 $0.00
1126F 10,563 8,566 $0.00
G8510 Screening for depression is documented as negative, a follow-up plan is not required 14,182 11,659 $0.00
1170F 2,752 2,404 $0.00
1125F 1,161 1,050 $0.00
3075F 2,213 2,004 $0.00
3008F 253 240 $0.00
3080F 1,292 1,124 $0.00
3079F 3,730 3,288 $0.00
91301 20 17 $0.00
3044F 12 12 $0.00
94761 23 21 $0.00